PERTH, Australia, Nov 18 (Bernama-BUSINESS WIRE) -- Regenerative medicine company Orthocell Limited is pleased to announce its regenerative cell therapy treatment, Ortho-ACITM, has been applied to its first patient in Singapore.
Singapore is the latest international market Orthocell has expanded Ortho-ACITM into, following its successful entry to Hong Kong earlier this year where the therapy was used on patients with articular cartilage damage within the knee joint.
http://mrem.bernama.com/viewsm.php?idm=25735
No comments:
Post a Comment